Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 27INDUSTRY 8OTHER_GOV 3NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Lung Neoplasms 6Mesothelioma, Malignant 3Uterine Cervical Neoplasms 2Mesothelioma 2Urinary Bladder Neoplasms 1Urethral Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Ovarian Neoplasms 1Gestational Trophoblastic Disease 1Endometrial Neoplasms 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Ovarian Epithelial 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Paclitaxel 14Carboplatin 14Radiotherapy 11Cisplatin 7Bevacizumab 7Docetaxel 5Cetuximab 4Erlotinib Hydrochloride 3Vinorelbine 2Surgical Procedures, Operative 2Radiotherapy, Conformal 2Radiosurgery 2Gemcitabine 2Etoposide 2Amplified Fragment Length Polymorphism Analysis 2sotorasib 1rucaparib 1pegfilgrastim 1Therapeutics 1Temozolomide 1Taxes 1Polymerase Chain Reaction 1Pneumonectomy 1Pharmacogenomic Testing 1Pemetrexed 1Panitumumab 1Neoadjuvant Therapy 1L-BLP25 1Injections 1Immunohistochemistry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Adenocarcinoma of Lung × Pemetrexed × Clear all
NCT02134912 2020-02-20

S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib

SWOG Cancer Research Network

Phase 2 Terminated
1 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡